Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 686
Selected: 0
NCT IDTitle
NCT00874497Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
NCT03902574Bioequivalence Study of Brexpiprazole Orally Disintegrating Tablets (ODT) 2mg
NCT01810783Brexpiprazole in Patients With Schizophrenia
NCT04641780"Brexpiprazole (Rexulti™) Safety and Efficacy Among Filipino Patients (RAISE) - A Post Marketing Surveillance Program"
NCT06674291Registry on the Effectiveness and Safety of the 9-month MDR-END Treatment Regimen in Korean Patients with FQ-sensitive MDR-TB (MDR-END Registry)
NCT01723904A Phase 3b, Open-Label, Safety and Efficacy Study of Rotigotine as Add-On Therapy With Low Doses of Pramipexole or Ropinirole in Patients With Advanced Parkinson's Disease
NCT00549978Safety and Pharmacokinetics of Probucol and Cilostazol
NCT02223715Prospective Observational Study of Clostridium Difficile Infection in Asian Pacific Countries
NCT07166887Phase I Study Multi Dose of 7.5mg Tolvaptan in Health Male
NCT04407312Cilostazol and Endothelial Progenitor Cell
NCT00272454Cilostazol in Acute Ischemic Stroke Treatment (CAIST)
NCT03908970Comparison Trial of OPA-15406 Ointment in Adult Patients With Atopic DermatitisSyndrome
NCT00705783Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
NCT01890694Tolvaptan to Reduce Length of Stay in Hospitalized Patients With Cirrhosis and Hyponatremia
NCT01739829Open-label Investigation of the Safety and Effectiveness of DIABECELL® in Patients With Type 1 Diabetes Mellitus
NCT01001702Oral Aripiprazole Open-Label Rollover Study
NCT00955812STAT3 Inhibitor for Solid Tumors
NCT03949894Evaluating the Safety and effectivenesS in Adult KorEaN Patients Treated With Tolvaptan for Management of Autosomal domInAnt poLycystic Kidney Disease
NCT01660256Confirmatory Study of OPC-12759 Ophthalmic Solution
NCT00666965A Placebo-Controlled Study for SPM 962 in Restless Legs Syndrome (RLS) Patients
NCT00080327Study of Three Doses of Aripiprazole in Patients With Acute Schizophrenia
NCT02237417Impact of Aripiprazole Once Monthly Medications on Changes in Brain Structure and Metabolism
NCT07461220Safety and Tolerability of IRL757 in Participants With Parkinson's Disease and Apathy
NCT00216723Efficacy and Safety of Aripiprazole in Patients With Schizophrenia or Bipolar Disorder
NCT06928142A Trial to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Participants With Sjögren's
NCT00882362Long-Term Administration Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive Disorder
NCT03303092Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Episodic Migraine
NCT03737474A Long-Term Study of Brexpiprazole in Patients With Major Depressive Disorder
NCT03141060Evaluating the Pharmacokinetics, Safety, and Tolerability of Delamanid in Combination With Optimized Multidrug Background Regimen (OBR) for Multidrug-Resistant Tuberculosis (MDR-TB) in HIV-Infected and HIV-Uninfected Children With MDR-TB
NCT01552772Safety and Tolerability Trial of Aripiprazole IM Depot Treatment in Adult Subjects With Schizophrenia Stabilized on Oral Antipsychotics Other Than Aripiprazole
NCT04150172To Evaluate Pharmacokinetics and Safety of Two Different Formulation of Rebamipide in Healthy Volunteers
NCT06973577P3b Short-term Study of CTN in Patients With ADHD and Comorbid Anxiety
NCT03854409A Trial of Single- and Multiple-doses of Aripiprazole in Adult Subjects With Schizophrenia or Bipolar I Disorder
NCT01876381A Phase 2, Multi-center, Open-label, Dose-finding Trial to Investigate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of OPC-41061 in Patients With Chronic Renal Failure Undergoing Hemodialysis or Hemodiafiltration
NCT05402111A Clinical Study That Will Assess How Food Moves Through the Stomach and Effects Blood Glucose Levels in Subjects With Schizophrenia Taking SEP-363856 or and Prior Antipsychotic (PA) Standard
NCT04241965A Single-blind, Placebo-controlled, Outpatient Trial to Assess the Effects of Single Oral Tablet Dose of OPC-214870
NCT00328367Aripiprazole Augmentation for Clozapine-Treated Patients With Refractory Schizophrenia
NCT02219009Open-label Study to Assess Usability of the Medical Information Device #1 (MIND1) System in Adults With Schizophrenia On Oral Aripiprazole
NCT03911401Comparison Trial of OPA-15406 Ointment in Pediatric Patients With Atopic Dermatitis
NCT02994394A Study of OPC-41061 Orally Disintegrating (OD) Tablets Using 2 Different Formulations and 2 Dosing Regimens in Healthy Adult Male Subjects
NCT05883956A Study Comparing Treatment Preference Between Oral Decitabine/Cedazuridine and Azacitidine in Myelodysplastic Syndrome, Low-Blast Acute Myeloid Leukemia, or Chronic Myelomonocytic Leukemia
NCT07086313A Trial to Evaluate the Efficacy and Safety of EB-1020 in Pediatric Patients With ADHD
NCT01994473Study Assessing the Safety, Tolerability, and Pharmacokinetics of SEP-363856 in Male and Female Subjects With Schizophrenia
NCT02091882Substudy of the Accuracy of Ingestible Event Marker (IEM) Detection by the Medical Information Device #1 (MIND1)
NCT01856634Pharmacokinetic and Safety Trial to Determine the Appropriate Dose for Pediatric Patients With Multidrug Resistant Tuberculosis
NCT03048747A Multicenter Trial to Investigate the Efficacy and Safety of Tolvaptan in Patients With Hyponatremia in SIADH
NCT01014416Pharmacokinetics/Pharmacodynamics (PK/PD) Characteristics of Tolvaptan Tablet in Korean Healthy Male
NCT00094432A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode
NCT01423903Phase 1, Open-label Trial to Determine Safety of OPB-51602 in Subjects With Advanced Cancer
NCT01349335Dose Exploring and Setting Study for Tolvaptan to Treat Hepatic Cirrhosis With Ascites